Diagnosis, pathogenesis and treatment of myositis: recent advances

被引:82
作者
Carstens, P. -O. [1 ]
Schmidt, J. [1 ,2 ,3 ]
机构
[1] Univ Med Ctr Gottingen, Neurol Clin, D-37073 Gottingen, Germany
[2] Univ Med Ctr Gottingen, Deptartment Neuroimmunol, Inst Multiple Sclerosis Res, D-37073 Gottingen, Germany
[3] Univ Med Ctr Gottingen, Hertie Fdn, D-37073 Gottingen, Germany
关键词
muscle immunology; disease; myositis; neuroimmunology; INCLUSION-BODY MYOSITIS; INTERSTITIAL LUNG-DISEASE; IDIOPATHIC INFLAMMATORY MYOPATHIES; CYTOSOLIC 5'-NUCLEOTIDASE 1A; SIGNAL RECOGNITION PARTICLE; MEMBRANE ATTACK COMPLEX; NECROTIZING MYOPATHY; INTRAVENOUS IMMUNOGLOBULIN; AMYOPATHIC DERMATOMYOSITIS; JUVENILE DERMATOMYOSITIS;
D O I
10.1111/cei.12194
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dermatomyositis (DM), polymyositis (PM), necrotizing myopathy (NM) and inclusion body myositis (IBM) are four distinct subtypes of idiopathic inflammatory myopathies - in short myositis. Recent studies have shed some light on the unique pathogenesis of each entity. Some of the clinical features are distinct, but muscle biopsy is indispensable for making a reliable diagnosis. The use of magnetic resonance imaging of skeletal muscles and detection of myositis-specific autoantibodies have become useful additions to our diagnostic repertoire. Only few controlled trials are available to substantiate current treatment approaches for myositis and hopes are high that novel modalities will become available within the next few years. In this review we provide an up-to-date overview of the pathogenesis and diagnostic approach of myositis. We aim to present a guide towards therapeutic and general management.
引用
收藏
页码:349 / 358
页数:10
相关论文
共 109 条
[1]   Malignancy in Myositis [J].
Abou Zahr, Zaki ;
Baer, Alan N. .
CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (03) :208-215
[2]   Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies [J].
Alexanderson, Helene ;
Lundberg, Ingrid E. .
CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (02) :201-207
[3]   INCLUSION-BODY MYOSITIS - TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN [J].
AMATO, AA ;
BAROHN, RJ ;
JACKSON, CE ;
PAPPERT, EJ ;
SAHENK, Z ;
KISSEL, JT .
NEUROLOGY, 1994, 44 (08) :1516-1518
[4]   A Randomized, Pilot Trial of Etanercept in Dermatomyositis The Muscle Study Group [J].
Amato, Anthony A. ;
Tawil, Rabi ;
Kissel, John ;
Barohn, Richard ;
McDermott, Michael P. ;
Pandya, Shree ;
King, Wendy ;
Smirnow, Alexis ;
Annis, Christine ;
Roe, Kristen ;
Tawil, Rabi ;
McDermott, Michael P. ;
Janciuras, Joanne ;
Dilek, Nuran ;
Martens, William B. ;
Eastwood, Eileen ;
Amato, Anthony ;
Cochrane, Thomas ;
Donlan, Merideth ;
Chused, Samantha ;
Roe, Kristen ;
Barohn, Richard ;
Dimachkie, Mazen ;
Aires, Daniel J. ;
Latinis, Kevin M. ;
Herbelin, Laura ;
Michaels, Hiwot ;
Cupler, Edward ;
Deodhar, Atul ;
Simpson, Eric ;
Burusnukul, Prinyarat ;
Edgar, Eric ;
Serdar, Andrea ;
Brennan, Thomas ;
Gance, Kathryn ;
Kissel, John ;
Freimer, Miriam L. ;
Hackshaw, Kevin V. ;
Lawson, Victoria ;
King, Wendy M. ;
Bartlett, Amy ;
Wolfe, Gil ;
Nations, Sharon ;
McLin, Rhonda ;
Gorham, Nina ;
Briemberg, Hannah ;
Chapman, Kristine M. ;
Dutz, Jan P. ;
Wilson, Judy ;
Varelas, Franca .
ANNALS OF NEUROLOGY, 2011, 70 (03) :427-436
[5]   Pathogenic Considerations in Sporadic Inclusion-Body Myositis, a Degenerative Muscle Disease Associated With Aging and Abnormalities of Myoproteostasis [J].
Askanas, Valerie ;
Engel, W. King ;
Nogalska, Anna .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (08) :680-693
[6]   Epidemiology of inclusion body myositis in the Netherlands:: A nationwide study [J].
Badrising, UA ;
Maat-Schieman, M ;
van Duinen, SG ;
Breedveld, F ;
van Doorn, P ;
van Engelen, B ;
van den Hoogen, F ;
Hoogendijk, J ;
Höweler, C ;
de Jager, A ;
Jennekens, F ;
Koehler, P ;
van der Leeuw, H ;
de Visser, M ;
Verschuuren, JJ ;
Wintzen, AR .
NEUROLOGY, 2000, 55 (09) :1385-1387
[7]   Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo [J].
Badrising, UA ;
Maat-Schieman, MLC ;
Ferrari, MD ;
Zwinderman, AH ;
Wessels, JAM ;
Breedveld, FC ;
van Doorn, PA ;
van Engelen, BGM ;
Hoogendijk, JE ;
Höweler, CJ ;
de Jager, AE ;
Jennekens, FGI ;
Koehler, PJ ;
de Visser, M ;
Viddeleer, A ;
Verschuuren, JJ ;
Wintzen, AR .
ANNALS OF NEUROLOGY, 2002, 51 (03) :369-372
[8]   Type I interferon pathway in adult and juvenile dermatomyositis [J].
Baechler, Emily C. ;
Bilgic, Hatice ;
Reed, Ann M. .
ARTHRITIS RESEARCH & THERAPY, 2011, 13 (06)
[9]   Pilot trial of etanercept in the treatment of inclusion-body myositis [J].
Barohn, RJ ;
Herbelin, L ;
Kissel, JT ;
King, W ;
McVey, AL ;
Saperstein, DS ;
Mendell, JR .
NEUROLOGY, 2006, 66 :S123-S124
[10]   Steroid myopathy in cancer patients [J].
Batchelor, TT ;
Taylor, LP ;
Thaler, HT ;
Posner, JB ;
DeAngelis, LM .
NEUROLOGY, 1997, 48 (05) :1234-1238